A man walking around a room wearing a helmet that records his brain function would have seemed like science fiction five years ago.
Pfizer wins first US approval for pentavalent meningococcal vaccine
Pfizer on Friday won approval for its next mass-market vaccine, a pentavalent meningococcal vaccine covering the most common serogroups infecting children and young adults ages